Cost–Benefit Analysis in Health Care: the Case of Bariatric Surgery Compared With Diet
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F20%3A00337416" target="_blank" >RIV/68407700:21460/20:00337416 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.1016/j.clinthera.2019.12.001" target="_blank" >https://doi.org/10.1016/j.clinthera.2019.12.001</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.clinthera.2019.12.001" target="_blank" >10.1016/j.clinthera.2019.12.001</a>
Alternative languages
Result language
angličtina
Original language name
Cost–Benefit Analysis in Health Care: the Case of Bariatric Surgery Compared With Diet
Original language description
The aim of the present study was to assess, by using a cost–benefit analysis, the net monetary benefit (NMB) of bariatric surgery compared with diet (including physical exercise) for obese patients, from both an Italian payer perspective and the broader societal perspective. The study considered the following groups of patients: (1) patients with a body mass index (BMI) >=40 kg/m2 without complications + patients with BMI >=35 kg/m2 with complications; (2) patients with BMI >=35 kg/m2 and diabetes; and (3) patients with BMI ranging from 30 to 35 kg/m2 and diabetes. A Markov model was developed to project the lifetime health outcomes (life years and quality-adjusted life years [QALYs]) and costs associated with bariatric surgery and diet for the considered groups of patients. The clinical effectiveness of each strategy was based on the likelihood of experiencing cardiovascular events or events related to the presence of diabetes. Data on clinical effectiveness, quality of life, productivity losses, and out-of-pocket costs were mainly derived from the literature; direct costs were obtained from official tariffs or the literature. Different scenarios were considered for the analyses in addition to the base case. According to both perspectives considered, the NMB was calculated by first assuming a willingness-to-pay threshold (30,000 per QALY), then converting health benefits (QALYs) into the common monetary metric (ie, the euro). NMB was calculated as follows: (incremental benefit x willingness-to-pay – incremental cost).
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30304 - Public and environmental health
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Clinical Therapeutics
ISSN
0149-2918
e-ISSN
1879-114X
Volume of the periodical
42
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
23
Pages from-to
"60"-"75.e7"
UT code for WoS article
000516654800008
EID of the result in the Scopus database
2-s2.0-85078022563